New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 14, 2014
08:47 EDTDTV, NDAQ, MHFI, MCK, CAKFY, FOXA, SHLD, TGT, VTR, MYL, ACT, BF.A, BF.B, BEAM, LMCA, CHTR, TWC, PFE, VRX, HCNOn the Fly: Periodicals Wrap
WSJ: DirecTV (DTV) wants Weather Channel fee reduction as apps take hold...Brown-Forman (BF.A, BF.B) may benefit from Beam (BEAM) deal...REUTERS: Malone (LMCA, CHTR) seeks consolidation in Time Warner Cable (TWC) bid...Pfizer's (PFE) generics unit attracts several suitors (VRX, ACT, MYL)...Nasdaq (NDAQ), S&P (MHFI) interested in acquisitions to grow index businesses...BLOOMBERG: McKesson (MCK) considers JV following failure of Celesio (CAKFY) bid...Fox (FOXA) won't participate in network TV’s pilot season...Sears (SHLD) may be cut by S&P...OTHER NEWS: Target's (TGT) problems may benefit security firms, NY Times reports...Ventas (VTR) and Health Care REIT (HCN) held talks, dealReporter reports.
News For B;BEAM;LMCA;CHTR;TWC;PFE;VRX;ACT;MYL;NDAQ;MHFI;MCK;CAKFY;FOXA;SHLD;TGT;VTR;HCN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>
October 8, 2014
12:36 EDTSHLDSears calls recently published article 'misleading'
Subscribe for More Information
12:35 EDTSHLDSears says 'has financial flexibility' and is 'meeting its obligations'
12:25 EDTSHLDOn The Fly: Midday Wrap
Subscribe for More Information
11:04 EDTTWCComcast shareholders approve stock issuance for Time Warner Cable merger
Subscribe for More Information
11:03 EDTTWCComcast shareholders approve stock issuance for Time Warner Cable merger
Subscribe for More Information
10:55 EDTPFELeerink pharmaceuticals analyst holds an analyst/industry conference call
Analysts discuss prospects for drugs that raise HDL cholesterol, effects of CETP mechanism, expectations for REVEAL data and the potential place for CETP inhibitors in a crowded hypersholesterolemia landscape on an Analyst/Industry conference call to be held on October 9 at 11 am.
10:38 EDTSHLDHigh option volume stocks
High option volume stocks: FRAN RMTI ACM CY CLNY SMH BEAV SIG CTB DUG SHLD
10:24 EDTSHLDSears vendor to withhold products, Bloomberg reports
Subscribe for More Information
10:23 EDTSHLDSears Holdings volatility spikes after Bloomberg says vendor to halt shipments
Sears Holdings October weekly call option implied volatility is at 200 above a level of 100 from the open, October is at 127, November is at 88, December is at 78, March is at 68; compared to its 26-week average of 54 according to Track Data, suggesting large near term price movement after Bloomberg says vendor to halt shipments.
10:11 EDTSHLDSears drops 9% after Bloomberg says vendor to halt shipments
Subscribe for More Information
10:00 EDTMCKOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:42 EDTACTSalix shares should be bought on weakness, says Sterne Agee
After Reuters yesterday afternoon reported that Actavis (ACT) plans to make a new merger approach to Allergan (AGN), Sterne Agee believes that Salix's standalone value is $162. The firm expects the shares to reach that level following approval of its Xifaxan IBS-D drug after the February 2015 PDUFA date.
08:09 EDTPFEPfizer presents LP2086 Phase 2 study data
Pfizer announced it will present the results of a Phase 2, randomized study to evaluate co-administration of the company’s investigational meningococcal group B vaccine, bivalent recombinant LP2086, or rLP2086, with a licensed quadrivalent human papillomavirus vaccine at IDWeek 2014. Data demonstrated immune responses to both vaccines were generated after concomitant administration of bivalent rLP2086 and HPV4. Prespecified noninferiority criteria were met for the bivalent rLP2086 antigens studied and three of the four antigens for HPV4. Primary immunogenicity endpoints, measured after the third dose, included geometric mean titers against HPV antigens in Groups 1 and 3 and human complement serum bactericidal assay GMTs against meningococcal group B disease test strains in Groups 1 and 2. Secondary immunogenicity endpoints included the rate of seroconversion to HPV antigens. Safety of bivalent rLP2086 was assessed after concomitant administration with HPV4 or saline. The prespecified noninferiority criteria were met for three of four HPV antigens and both meningococcal group B disease test strains. Seroconversion for all four HPV antigens was achieved by 99% or more of the subjects for the groups that received HPV4 concomitantly with bivalent rLP2086 or with saline. More local reactions occurred following administration of bivalent rLP2086 compared with saline but the incidence of these reactions did not increase with subsequent vaccine administration. The rates of local and systemic reactions were comparable when bivalent rLP2086 was given with HPV4 to bivalent rLP2086 given alone.
07:19 EDTPFECBI to hold a conference
Subscribe for More Information
07:18 EDTPFEInfectious Diseases Society of America to hold a conference
ID Week 2014 is being held in Philadelphia on October 8-12.
07:13 EDTFOXAHulu may cut number ads on Hulu Plus, NY Post reports
Hulu (FOXA, DIS, CMCSA) CEO Mike Hopkins is looking to cut back on the number of ads that appear on Hulu Plus, reports the New York Post. According to an executive close to the company, Hulu and its partners are “always looking at a variety of ways to create the best possible experience for our viewers and advertisers including reducing the ad load." Reference Link
06:47 EDTMYL, ACTLawmakers may push for new regulations on generic drug makers, NY Times says
After the prices of some generic drugs soared more than 1,000% over the last year, two influential members of Congress are probing the sector and threatening to look to impose new regulations on it, according to The New York Times. Generic drug makers include Teva (TEVA), Mylan (MYL), Actavis (ACT), and Lannett (LCI).Reference Link
06:23 EDTVRX, ACTActavis more inclined to pursue Allergan over Salix, says Citigroup
Subscribe for More Information
06:16 EDTSHLDSears Holdings volatility elevated
Subscribe for More Information
06:16 EDTMCKMcKesson initiated with a Buy at Citigroup
Target $235.
1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use